Papers on
GM-CSF
Histamine receptor 2 modifies dendritic cell responses to microbial ligands.O'Mahony et al., Zürich, Switzerland. In J Allergy Clin Immunol, 01 Apr 2013
Lactobacillus rhamnosus, which secretes histamine, significantly suppressed Peyer patch IL-2, IL-4, IL-5, IL-12, TNF-α, and GM-CSF secretion in wild-type but not H2R-deficient animals.
Protease-activated receptor-2 induces proinflammatory cytokine and chemokine gene expression in canine keratinocytes.Tsujimoto et al., Tokyo, Japan. In Vet Immunol Immunopathol, 13 Mar 2013
Stimulation of CPEK cells with trypsin induced significant upregulation of the mRNA expression levels of tumor necrosis factor alpha (TNF-α, P<0.05), granulocyte-macrophage colony-stimulating factor (GM-CSF, P<0.01), thymus and activation regulated chemokine (TARC/CCL17, P<0.01), and interleukin 8 (IL-8/CXCL8, P<0.01).
Basophil modulation by cytokine instruction.Voehringer, Erlangen, Germany. In Eur J Immunol, Oct 2012
IL-3, GM-CSF, and thymic stromal lymphopoietin activate the STAT5 pathway that promotes proliferation, activation, and cytokine secretion but also induces a negative feedback loop via Pim-1 and SOCS proteins.
The evolving role of immunotherapy in prostate cancer.Gerritsen, Amsterdam, Netherlands. In Ann Oncol, Sep 2012
PROSTVAC(®)-VF, a poxvirus-based vaccine engineered to present prostate-specific antigen (PSA) and three immune costimulatory molecules, and GVAX, a vaccine consisting of two prostate cancer cell lines (LnCAP and PC3) and genetically modified to secrete granulocyte-macrophage colony-stimulating factor (GM-CSF), both showed promising results in phase II studies, although GVAX failed to meet its primary end point of overall survival when compared with docetaxel in a phase III study.